- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/263 - 2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
Patent holdings for IPC class C07D 207/263
Total number of patents in this class: 78
10-year publication summary
|
6
|
5
|
5
|
5
|
3
|
9
|
3
|
7
|
8
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 518 |
11 |
| Novartis AG | 11234 |
7 |
| Takeda Pharmaceutical Company Limited | 2946 |
5 |
| California Institute of Technology | 3932 |
3 |
| Board of Regents, The University of Texas System | 5648 |
3 |
| Uniwersytet Jagiellonski | 255 |
3 |
| Warszawski Uniwersytet Medyczny | 63 |
3 |
| Novartis Pharmaceuticals Corporation | 52 |
2 |
| BASF SE | 20501 |
2 |
| Vertex Pharmaceuticals Incorporated | 1583 |
2 |
| Emory University | 1587 |
2 |
| Pardes Biosciences, Inc. | 23 |
2 |
| Guangzhou Anovent Pharmaceutical Co. Ltd | 19 |
2 |
| The Regents of the University of California | 19590 |
1 |
| Merck Patent GmbH | 5864 |
1 |
| Uop LLC | 4188 |
1 |
| Abbvie Inc. | 1786 |
1 |
| 92229129 Quebec Inc. | 7 |
1 |
| Atrogi AB | 53 |
1 |
| Board of Trustees of Michigan State University | 1161 |
1 |
| Other owners | 24 |